Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
29-Apr-2019Resequencing study confirms host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosisMoore, C; Blumhagen, RZ; Yang, IV; Walts, A; Powers, J, et al
15-Jul-2019The transferrin receptor CD71 delineates functionally distinct airway macrophage subsets during idiopathic pulmonary fibrosisAllden, SJ; Ogger, PP; Ghai, P; McErlean, P; Hewitt, R, et al
29-Sep-2019Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trialMaher, TM; Corte, TJ; Fischer, A; Kreuter, M; Lederer, DJ, et al
24-Jul-2019Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis.Hobbs, BD; Putman, RK; Araki, T; Nishino, M; Gudmundsson, G, et al
20-May-2019Nintedanib for systemic sclerosis-associated interstitial lung diseaseDistler, O; Highland, KB; Gahlemann, M; Azuma, A; Fischer, A, et al
Mar-2019Regularized latent class model for joint analysis of high dimensional longitudinal biomarkers and a time-to-event outcomeSun, J; Herazo-Maya, JD; Molyneaux, PL; Maher, TM; Kaminski, N, et al
1-Sep-2019Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled studyMaher, TM; Stowasser, S; Nishioka, Y; White, ES; Cottin, V, et al
7-Nov-2019Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung diseaseAlfieri, V; Crisafulli, E; Visca, D; Chong, WH; Stock, C, et al